| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.09 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |